Position in SCLX
as of Mar 31, 2026
· filed Jun 3, 2026
Position Value
$93
-$77 QoQ
Shares Held
14
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NewEdge Advisors, LLC holds $721,115,080 across 17 Drug Manufacturers - General names. SCLX ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
888,033 | $217,070,786 | |
| 2 | LLY |
ELI LILLY & Co
|
184,095 | $169,325,058 | |
| 3 | ABBV |
AbbVie Inc.
|
632,140 | $137,484,128 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
392,435 | $54,693,665 | |
| 5 | MRK |
Merck & Co., Inc.
|
341,876 | $41,124,264 | |
| 6 | AMGN |
Amgen Inc
|
95,939 | $33,756,137 | |
| 7 | PFE |
Pfizer Inc
|
712,319 | $20,001,917 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
226,056 | $13,710,296 |
All Filings in SCLX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $93 | 14 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $170 | 14 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $275 | 14 | Shares | Sole | 2025-11-17 | |
| No filing history on record for this holder in this stock. | ||||||